Executive Management

Rami Levin, President and Chief Executive Officer

Education: Bachelor's degree in biology and an MBA, majoring in International Marketing

Other assignments: Member of the board of advisors, Life Science Cares

Previous assignments: President of Sobi Inc., Vice President Marketing of EMD Serono, Inc., Managing Director of the Merck Group in Scandinavia, Global Marketing Director of the Merck Group

No. of shares: 0

No. of warrants: 710,313

 

Rudolf Baumgartner, CMO and Head of Clinical Development

Education: Medical Degree; specialized in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine. Completed Post-Graduate Work in the Laboratory of Molecular Immunology at the National Heart and Blood Institute (NHLBI) at the National Institutes of Health (Bethesda, Maryland)

Previous assignments: Chief Medical Officer, Flatley Discovery lab. Executive Vice President and Chief Medical Officer, Inotek Pharmaceuticals. VP and Therapeutic Area Head of Respiratory and Immunology, Sepracor. Director Clinical Research, Merck & Co.

No. of shares: 0

No. of warrants: 0

 

Jørgen Drejer, Ph.D., CSO and founder of Saniona

Education: PhD in neurobiology

Other assignments: Member of the board and CSO of Saniona A/S. Board member of 2CureX AB and 2CureX A/S.

Previous assignments: CEO of Saniona. Executive Vice President, Board member, Research Director and co-founder of NeuroSearch A/S. Member of the Board of Directors of Atonomics A/S, NSGene A/S, Origio A/S, Zgene A/S, Aktieselskabet af 20. November 2003, Delta Reader A/S, Azign Bioscience A/S, Force Technology, Ellegaard Göttingen Minipigs ApS, and Monta Biosciences A/S.

No. of shares: 2,344,711

No. of warrants: 161,704 of series TO 2 and TO 3

 

Anita Milland, Interim CFO and Head of IR

Education: Bachelor of Commerce in Accounting

Other assignments: Partner and owner of Jørgensen & Miland Search & Selection ApS

Previous assignments: VP Finance & Administration of Saniona A/S. CFO of NeuroSearch A/S. Member of the board of directors NeuroSearch Sweden AB, Poseidon Pharmaceuticals A/S and NsExplorer A/S.

No. of shares: 11,200

Employee options: 12,750

No. of warrants: 804 of series TO 2 and TO 3